Biologists unravel full sequence of DNA repair mechanism

January 25, 2021

Every living organism has DNA, and every living organism engages in DNA replication, the process by which DNA makes an exact copy of itself during cell division. While it's a tried-and-true process, problems can arise.

Break-induced replication (BIR) is a way to solve those problems. In humans, it is employed chiefly to repair breaks in DNA that cannot be fixed otherwise. Yet BIR itself, through its repairs to DNA and how it conducts those repairs, can introduce or cause genomic rearrangements and mutations contributing to cancer development.

"It's kind of a double-edged sword," says Anna Malkova, professor in the Department of Biology at the University of Iowa, who has studied BIR since 1995. "The basic ability to repair is a good thing, and some DNA breaks can't be repaired by other methods. So, the idea is very good. But the outcomes can be bad."

A new study led by Malkova, published Jan. 20 in the journal Nature, seeks to tease out BIR's high risk-reward arrangement by describing for the first time the beginning-to-end sequence in BIR. The biologists developed a new technique that enabled them to study in a yeast model how BIR operates throughout its repair cycle. Until now, scientists had only been able to study BIR's operations at the beginning and end stages. The researchers then introduced obstructions with DNA replication, such as transcription--the process of copying DNA to produce proteins--that are believed to be aided by BIR.

"Our study shows that when BIR comes to the rescue at these collisions, its arrival comes at a very high price," says Malkova, the study's corresponding author. "When BIR meets transcription, it can introduce even more instability, which can lead to even higher mutations. As a result, we think that instabilities that mainly were found at collisions between transcription and replication that have been suggested to lead to cancer might be caused by BIR that came to the rescue. It comes, it rescues, but it's kind of questionable how helpful it really is."

Scientists have known how BIR works at some stages. For example, they know the DNA repair apparatus forms a bubble of sorts around the damaged DNA, then moves forward, unzipping the DNA, copying intact segments, and finally transferring those copied segments to a new DNA strand.

But what remained elusive was following BIR throughout its entire repair cycle. Using a technique involving Droplet Digital PCR and a new DNA purification method developed by biology graduate student Liping Liu, the researchers were able to observe BIR from beginning to end.

"If you imagine this as a train, Liping installed a bunch of stations, and she watched how the train proceeded at each station, tracking the increase in DNA at each station, how much increase is occurring at each station, and thus, in aggregate, how the entire process unfolds," Malkova explains.

The team then intentionally introduced obstructions at some stations--transcription and another obstruction called internal telomere sequences--to observe how BIR responded to the obstacles. One finding: when transcription is introduced near the beginning of the BIR process, the repairs fail to commence, as if they're being suppressed. Also, the researchers found the orientation of the transcription with respect to BIR can affect the repair cycle and may be an important factor affecting instability that can promote cancer in humans.

"Scientists already know there's a lot of instability in places where high transcription meets normal replication," Malkova says. "What we did not know until now is where is it coming from and why is it happening."

The first author of the study, "Tracking break-induced replication shows that it stalls at roadblocks," is Liu, who is a sixth-year graduate student in Malkova's lab. Co-authors from Iowa include Beth Osia, Jerzy Twarowski, Juraj Kramara, Rosemary Lee, Hanzeng Li, and Rajula Elango (now at Beth Israel Deaconess Medical Center and Harvard Medical School). Co-authors from the Baylor College of Medicine include Zhenxin Yan, Luyang Sun, Sandeep Kumar, Weiwei Dang, and Grzegorz Ira.
The National Institutes of Health funded the research.

University of Iowa

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to